CLINICAL_TRIALS
trial_result
· 2019-11-20
Clinical Trial Update: The Safety, Pharmacokinetic Profile and Efficacy of Raltegravir in HIV-infected Patients at Least 60 Years of Age [Phase 4]
Summary
Phase 4 trial update on safety, pharmacokinetics, and efficacy of raltegravir in HIV-infected patients aged 60 and over.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2019-11-20